The Regenerative Medicine Industry Interface (RMI2)

BioMedVic is pleased to be a founding partner of the Regenerative Medicine Industry Interface (RMI2).

This consortium brings together

  • Basic and applied research capability (Australian Regenerative Medicine Institute at Monash University, CSIRO, The University of Melbourne) together with industry and networking associations (BioMelbourne Network, BioMedVic, AusBiotech) and an international technology transfer hub in partnership with the regenerative medicine industry.
  • Access to high calibre research students through the Monash University Graduate Research Industry Program (GRIP) for PhD students and Monash University Business School for Executive MBA students.
  • Commercialisation expertise and international access through a satellite hub of the Centre for Commercialisation of Regenerative Medicine (CCRM).

RMI2 is an initiative of the Australian Regenerative Medicine Institute (ARMI) in partnership with Monash and Melbourne Universities, the BioMelbourne Network and Industry Partners, to progress opportunities in Australia through research excellence, highly skilled workforce and a globally connected platform for commercialisation and investment.

RMI2 is offering two industry-led PhD programs for potential students interested in working in regenerative medicine. See the ARMI website for more information.